 |
Useful links MASCC Multinational Association of supportive Care in Cancer www.mascc.org National Cancer Institute
www.cancer.gov National Health Service UK
1. Tiberg et al Tiberg, F., Cavallin-Ståhl, E., Linden, M., Thuresson, K. and Hadjieva, T. Treatment of oral mucositis pain by a bioadhesive barrier forming lipid solution. Support Care Cancer 2009, 17(7):918
2. Svanberg et al Svanberg, A., Birgegård, G. and Öhrn, K. The effect of oral lipid solution and cryo-therapy on severe side effects of intensive chemotherapy. Support Care Cancer 2010, 18 (3), 67-220
3. Sonis ST Sonis ST, Oral Mucositis in Cancer Therapy J Support Oncology 2004, 2(3):3-8. 4. Epstein et al. 2006 Epstein JB and Klasser GD. Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy. Expert Opinion Emerging Drugs 200, 11(2): 353-373.
5. Vera-Llonch et al. 2006 Vera-Llonch M, Oster G, et al. Oral mucositis in patients undergoing radiation treat- ment for head and neck carcinoma Cancer 2006, 106(2):329-336 |
© Camurus AB, Ideon Science Park, 223 70 Lund, Sweden, info@camurus.com, www.camurus.com
episil® is Camurus registered trademark in US. Pending trademark applications in additional territories
episil® is Camurus registered trademark in US. Pending trademark applications in additional territories